Health
Study explores women’s interest in long-acting injectable antiretroviral therapy – News-Medical.Net
A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women…
A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women with a history of injection–including medical purposes and substance use. The findings appear in the journal AIDS Patient Care and STDs.
Currently, most HIV therapies for treatment and prevention (pre-exposure prophylaxis, PrEP) necessitate daily pills, which pose barriers to adherence. Recently, however, LAI for HIV has emerged as an alternative…
-
General22 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General21 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General23 hours agoChina says Donald Trump’s Golden Dome plans risk weaponising space
-
Noosa News20 hours agoLord mayor promises to review medium density planning laws